Angiogenesis inhibitors and pharmaceutical/cosmetic applications thereof
US7396953B2 · kind B2 · utility
1Cited by
1References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 21, 2006 |
| Grant date | Jul 8, 2008 |
| Priority date | — |
| Expiry date | Dec 22, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel derivatives of fumagalone have the general formula (I):and are useful angiogenes is inhibitors; these can be formulated into pharmaceutical compositions suited for human or veterinary medicine, or can be formulated into cosmetic compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.